Urakawa, Hiroshi <br/><br/>
A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610.  [electronic resource] 

 -  Japanese journal of clinical oncology  Apr 2019 
 - 379-382 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1465-3621 
<br/><br/><label>Standard No.: </label>10.1093/jjco/hyz004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Neoplasms--drug therapy<br/>Bone and Bones--pathology<br/>Curettage--methods<br/>Denosumab--therapeutic use<br/>Female<br/>Giant Cell Tumor of Bone--drug therapy<br/>Humans<br/>Japan<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Osteotomy--adverse effects<br/>Postoperative Complications--prevention & control<br/>Research Design